| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Note receivable | - | 3,486 | ||
| Cash and cash equivalents | 4,546 | 3,471 | ||
| Accounts receivable, net of allowances | 761 | 1,735 | ||
| Inventories | 409 | 444 | ||
| Prepaid expenses and other current assets | 59 | 51 | ||
| Total current assets | 5,775 | 9,187 | ||
| Total, at cost | 2,237 | - | ||
| Less accumulated depreciation | 573 | - | ||
| Equipment and leasehold improvements, net | 1,664 | 1,664 | ||
| Other non-current assets | 116 | 102 | ||
| Note receivable, net of current-Entities Excluding Partially Owned Subsidiary | - | 86 | ||
| Operating lease right-of-use assets, net | 1,070 | 937 | ||
| Financing lease right-of-use asset, net | 400 | 418 | ||
| Note receivable, net of current-Partially Owned Subsidiary | 82 | 82 | ||
| Investment in south korean joint venture | 23 | 23 | ||
| Total assets | 9,130 | 12,499 | ||
| Accounts payable and accrued expenses-Entities Excluding Partially Owned Subsidiary | 891 | 1,430 | ||
| Accounts payable and accrued expenses-Partially Owned Subsidiary | 1,134 | 1,183 | ||
| Debt obligations-Partially Owned Subsidiary | 1,033 | 1,033 | ||
| Debt obligations | 83 | 83 | ||
| Operating lease liabilities | 142 | 105 | ||
| Finance lease liability | 88 | 88 | ||
| Deposits | 80 | 158 | ||
| Total current liabilities | 3,451 | 4,080 | ||
| Debt obligations, net of current-Entities Excluding Partially Owned Subsidiary | 190 | 199 | ||
| Debt obligations, net of current-Partially Owned Subsidiary | 1,010 | 971 | ||
| Operating lease liabilities, net of current | 969 | 872 | ||
| Finance lease liability, net of current | 295 | 317 | ||
| Total long-term liabilities | 2,464 | 2,359 | ||
| Total liabilities | 5,915 | 6,439 | ||
| Common stock, 0.00067 par value, 550,000,000 shares authorized, 311,452,683 and 301,274,243 shares issued, at september 30, 2025 and december 31, 2024 | 208 | 205 | ||
| Additional paid-in capital | 164,894 | 160,601 | ||
| Accumulated deficit | -158,327 | -151,848 | ||
| Accumulated other comprehensive loss | -195 | -203 | ||
| Total biolargo inc. and subsidiaries stockholders equity | 6,580 | 8,755 | ||
| Non-controlling interest (notes 8, 9, 10) | -3,365 | -2,695 | ||
| Total stockholders equity | 3,215 | 6,060 | ||
| Total liabilities and stockholders equity | 9,130 | 12,499 | ||
BIOLARGO, INC. (BLGO)
BIOLARGO, INC. (BLGO)